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Frutalin is a homotetrameric partly glycosylated α-D-galactose-binding lectin of biomedical
interest from Artocarpus incisa (breadfruit) seeds, belonging to the jacalin-related lectins
family. As other plant lectins, frutalin is a heterogeneous mixture of several isoforms
possibly with distinct biological activities. The main problem of using such lectins as
biomedical tools is that “batch-to-batch” variation in isoforms content may lead to
inconstant results. The production of lectins by recombinant means has the advantage
of obtaining high amounts of proteins with deﬁned amino-acid sequences and more
precise properties. In this mini review, we provide the strategies followed to produce two
different forms of frutalin in two different microbial systems: Escherichia coli and Pichia
pastoris.The processing and functional properties of the recombinant frutalin obtained from
these hosts are compared to those of frutalin extracted from breadfruit. Emphasis is given
particularly to recombinant frutalin produced in P. pastoris, which showed a remarkable
capacity as biomarker of human prostate cancer and as apoptosis-inducer of cancer cells.
Recombinant frutalin production opens perspectives for its development as a new tool in
human medicine.
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OUTLINE
Plant lectins have attracted much attention for biomedical appli-
cations, especially due to their remarkable anti-tumor properties,
resulting from their ability to induce programmed cell death
and/or autophagocytosis in cancer cells (Liu et al., 2010; Fu et al.,
2011). Plant lectins are also relevant for biomedical diagnosis
(Mislovicova et al., 2009).
Frutalin is a plant lectin with reported immunomodulatory
(Brando-Lima et al., 2005,2006), anti-tumor (Oliveira et al., 2011),
and tumor biomarker (Oliveira et al., 2009b) properties, among
other capacities (de Vasconcellos Abdon et al., 2012), and is a
good example of how recombinant production of plant lectins
can be challenging but also advantageous for obtaining bioac-
tive derivatives for biomedical application. Frutalin is found
in extracts of Artocarpus incisa (breadfruit) seeds (Pineau et al.,
1990), from which it can be puriﬁed by afﬁnity chromatography
on cross-linked Adenanthera pavonina galactomannan (Moreira
et al., 1998). The name “frutalin” (hereinafter referred to as FTL)
is a composite of part of the Portuguese common name of
the lectin source plant (“fruta” of “fruta-pão”) followed by the
sufﬁx “-lin”. Although having sugar-binding preference toward
D-galactose, FTL presents a rather broad sugar-binding activity,
interacting also with other sugars, as D-mannose and D-glucose.
FTL belongs to the jacalin-related lectins family (JRLs, found in
the Moraceae plant family), speciﬁcally to the sub-family of the
galactose-speciﬁc lectins (gJRLs), as it presents high structural
homology, sugar speciﬁcity and sequential identity with jacalin
(the galactose-speciﬁc lectin of Artocarpus integrifolia seeds – jack-
fruit, the ﬁrst member of this family to be identiﬁed; Pineau et al.,
1990; Moreira et al., 1998; Oliveira et al., 2009a). FTL is character-
ized by a strong and identical agglutinating activity with human
erythrocytes of theABO system and rabbit erythrocytes, which has
no requirements for divalent metal cations (Moreira et al., 1998).
Interestingly, the hemagglutination activity (HA) of FTL is three
times higher than that of jacalin (Nobre et al., 2010). FTL has a
sophisticated processing. The conversion of the primary transla-
tion product of gJRL-mRNA into the protein includes a complex
series of co- and post-translational modiﬁcations including the
removal of the signal peptide (vacuolar targeting), a (partial) gly-
cosylation, removal of the N-terminal propeptide, the excision of
a linker tetrapeptide, to separate two polypeptide chains (α and β),
proper folding and oligomer assembly. Molecular cloning of the
FTL cDNA (excluding signal and propeptide), revealed that, as
jacalin, it may be encoded by a family of genes, each of them
containing 471 bp, corresponding to a protein of 157 amino-
acids, with a calculated molecular weight of 17.1 kDa (Oliveira
et al., 2009a). Twenty amino-acids correspond to the β-chain, 4
amino-acids to the linker “T-S-S-N” and 133 amino-acids cor-
respond to the α-chain (from N- to C-terminal). Several gJRLs
conserved regions of amino-acids were found in FTL sequences,
including the linker. The linker, and its processing, is speciﬁc
for the sub-group of the gJRLs, being absent in the other sub-
group (mannose-speciﬁc JRLs; Houles Astoul et al., 2002). FTL is
a heterogeneous mixture of several slightly different amino-acid
sequences sharing 93–97% of identity, with or without consen-
sus sequences for N-glycosylation (Asn-X-Thr/Ser) in the α-chain
(one of these potential N-glycosylation sites was also reported for
jacalin; Oliveira et al., 2009a). In fact, FTL is a partly glycosylated
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protein, with 2.1% of carbohydrates (Moreira et al., 1998). Differ-
ent FTL isoforms or iso-lectins (i.e., different mature sequences)
may have distinct biological activities, as reported for other plant
lectins (Raemaekers et al., 1999; Ohba et al., 2003). Under denatur-
ing conditions (SDS-PAGE), FTL presents two bands: the upper
band (15.5 kDa) corresponds to the highly glycosylated isoforms
of α chain, whereas the lower band (12 kDa) represents the
slightly or non-glycosylated isoforms of the same chain (Oliveira
et al., 2008). The β chain is not visible due to its low molecular
weight (2.1 kDa; Oliveira et al., 2008). In its native form, FTL is a
tetrameric molecule, consisting of four monomers bound by non-
covalent linkages, each containing one β and one α chain, forming
four sugar-binding sites, with a predominantly β sheet conforma-
tion (Moreira et al., 1998; Campana et al., 2002) and an apparent
molecular mass of 48–49 kDa (Moreira et al., 1998; Oliveira et al.,
2008). FTL is a robust protein as it is stable up to 60◦C and very
resistant to chemical denaturation (Campana et al., 2002).
Plant lectins are commonly isolated from their natural sources,
although this presents several disadvantages, as the resulting
isoforms. Recombinant production, mainly in microbial hosts,
is an interesting way to overcome this problem, whilst it may
allow to improve availability, ensure continuous supply and
facilitate puriﬁcation of lectins with interesting activities or
improved/tailor-made functionalities, particularly for biomedical
application (for a recent review see Oliveira et al., 2013).
This review describes the case study of the different strategies
applied for the production of FTL in the bacterium Escherichia coli
(Oliveira et al., 2009a; Costa, 2013; Costa et al., 2013a) and in the
yeast Pichia pastoris (Oliveira et al., 2008). Several variables were
considered for optimization: codon usage, strains, fusion part-
ners, induction conditions, and puriﬁcation methodology. Both
microorganisms are well-established platforms for the production
of recombinant proteins, including several approved biopharma-
ceutical products (Berlec and Strukelj, 2013; Gasser et al., 2013).
These are also the most employed hosts for the production of
recombinant lectins, namely plant lectins for biomedical purposes,
such as jacalin (Sahasrabuddhe et al., 2004, 2006), aviscumin
(from Viscum album; Zwierzina et al., 2011), PCL (from Polyg-
onatum cyrtonema; Li et al., 2011), Orysata (from Oryza sativa;
Al Atalah et al., 2011), and GNAmaize (from Galanthus nivalis;
Fouquaert et al., 2009). E. coli is commonly used to produce
non-glycosylated lectins, while P. pastoris is mainly employed to
overcome problems of insoluble expression of the bacterial system
and to produce glycosylated lectins. Thus, E. coli and P. pastoris
were chosen to produce non-glycosylated recombinant frutalin
(EcrFTL) and glycosylated recombinant frutalin (PprFTL), respec-
tively. The bio-molecular characterization of the recombinant FTL
obtained from each host in terms of processing, molecular weight,
HA and sugar-binding activity is herein presented. Finally, a main
focus is given to PprFTL due to its demonstrated anti-tumor and
tumor biomarker activities (Oliveira et al., 2009b, 2011).
PRODUCTION OF RECOMBINANT FRUTALIN IN E. coli
A FTL cDNA sequence was used for production of recombinant
FTL in E. coli by different strategies (Oliveira et al., 2009a). The
ﬁrst attempts to produce soluble EcrFTL in E. coli focused in the
use of engineered E. coli strains that have extra copies of rare
tRNAs and in the optimization of the induction conditions, but
resulted in low yields (Oliveira et al., 2009a; Costa, 2013). The
soluble production of EcrFTL from strain E. coli BL21 Codon
Plus RIPL (DE3), harboring the pET-25b(+) expression vector
(Novagen), was maximized to 16 mg/l by the implementation of
an experimental factorial design (Oliveira et al., 2009a; Figure 1).
However, all the experimental conditions resulted in EcrFTL pro-
duced predominantly as insoluble protein. Even though, EcrFTL
was puriﬁed from crude E. coli extracts by sequential size exclu-
sion (SEC) and cation ion exchange chromatography (IEC) that
yielded 76 μg of protein per liter of E. coli culture. Puriﬁed EcrFTL
migrated in SDS-PAGE gel as a homogeneous single-band protein
with a molecular mass of about 17 kDa, indicating that the linker
was not cleaved. Nevertheless, EcrFTL presented HA against rab-
bit erythrocytes, although it required more time to develop this
activity than FTL. Thus, the HA of FTL is not strictly dependent
on linker cleavage. In assays of HA inhibition by different sugars,
EcrFTL presented speciﬁcity for galactose; however, it could not be
puriﬁed by afﬁnity chromatography on A. pavonina galactoman-
nan, thus revealing lower sugar-binding afﬁnity than FTL. The
biomedical properties of this EcrFTL were not evaluated since the
amounts obtained through this strategy were unsatisfactory and
we were willing to improve them.
Taking into account the low production yields previously
obtained, fusion protein technology was afterward considered to
improve the soluble production and puriﬁcation of recombinant
FTL in E. coli. Eight fusion tags (His6, Trx, GST, NusA, MBP,
SUMO, H, and Fh8), included in pETM vectors (EMBL), were
evaluated in small-scale screening assays for recombinant FTL
solubility in four E. coli strains (Costa et al., 2013a; Figure 1).
All vectors provided a His6 tag for puriﬁcation of the EcrFTL
fusions by nickel afﬁnity (immobilized metal ion afﬁnity chro-
matography – IMAC). The Rosetta strain (DE3) was selected for
scale-up protein processing, namely puriﬁcation and solubility
evaluation before and after tag cleavage. The solubility enhancer
partners NusA, Trx, and Fh8 tags considerably improved the sol-
uble production of EcrFTL (in the order: NusA∼Fh8 > Trx),
being the protein soluble after their removal by TEV cleavage
(Tobacco Etch Virus protease). Interestingly, the cleaved and
puriﬁed EcrFTL from the Fh8 and Trx fusions presented higher
amounts than that cleaved from the NusA fusion protein (Costa
et al., 2013a). The fusion protein strategy boosted the availabil-
ity of EcrFTL by increasing its yield from μg to mg of active
protein per liter of E. coli culture whilst simplifying the com-
plete production and puriﬁcation protocol (Costa, 2013). IMAC
revealed to be a simpler, easier and quicker procedure than SEC
or IEC for EcrFTL puriﬁcation, and it also decreased EcrFTL
losses during puriﬁcation. Moreover, EcrFTL kept its HA when
fused to this partner (our unpublished results). However, the
His6FTL fusion (produced from vector pETM-11) was found to
be a very unstable protein, precipitating at physiological pH, and
thus being incompatible with cell culture conditions for evalua-
tion of its anti-tumor activity (our unpublished results). Among
the fusion partners tested, the Fh8 tag was pointed as a good
option for the production of soluble EcrFTL in E. coli because
of its advantageous low molecular weight and combined solubility
enhancer and puriﬁcation handle activities (Costa, 2013). The Fh8
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FIGURE 1 | Main strategies for the production of soluble recombinant FTL in Escherichia coli (A) and Pichia pastoris (B). Different frutalin codifying
genes were cloned in E. coli and P. pastoris, which deduced amino-acid sequences share 93% of identity (Table 2 in Oliveira et al., 2009a).
tag (Fasciola hepatica 8-kDa antigen) has been recently ranked
among the best solubility enhancer partners for recombinant
protein production in E. coli (Costa et al., 2013a, 2014). Fh8
was also shown as a suitable fusion partner for puriﬁcation of
recombinant proteins in E. coli by HIC (hydrophobic interac-
tion chromatography), with efﬁciencies comparable to those of
IMAC (Costa et al., 2013b). Besides improving EcrFTL solubil-
ity, the Fh8 tag increased EcrFTL stability, compared to the
His6 tag, and it did not interfere with the HA and structure
(in respect to β-sheet conformation) of EcrFTL, before and after
its cleavage (Costa, 2013). The anti-tumor activity of these two
versions of EcrFTL, the Fh8FTL and Fh8-cleaved FTL, is under
evaluation.
PRODUCTION OF RECOMBINANT FRUTALIN IN P. pastoris
PRODUCTION AND BIO-MOLECULAR CHARACTERIZATION
Frutalin has highly glycosylated isoforms and the presence of the
glycans may be important for its functional properties. Thus,
we planned to produce FTL in a microorganism capable of
performing glycosylation, namely using the strain P. pastoris
KM71H (Oliveira et al., 2008; Figure 1). FTL gene (encoding a
mature sequence; Oliveira et al., 2009a) was optimized based on
the codon usage of P. pastoris and integrated into the yeast genome
in frame at the C-terminal of the Saccharomyces α-factor prepros-
equence (MFα), to direct PprFTL into the secretory pathway, and
under the control of the strong methanol inducible AOX1 pro-
moter. PprFTL was produced in shake-ﬂasks and puriﬁed from
supernatants by SEC yielding 18–20 mg per liter of culture.
Important differences between the molecular and biological
properties of PprFTL and FTL were found (Oliveira et al., 2008).
The reason for that was the processing of FTL in P. pastoris, which
was different from that occurring in breadfruit. As also observed
in E. coli (Oliveira et al., 2009a), the FTL linker was not cleaved in
P. pastoris (conﬁrmed by N-terminal sequencing), thus suggesting
that this processing can be speciﬁc for higher eukaryotes. Fur-
thermore, the MFα secretion leader was incompletely removed,
resulting in PprFTL with one Glu-Ala repeat at its N-terminal,
decreasing its predicted PI (isoeletric point) from 8 to 5. These
repeats are commonly observed in heterologous proteins secreted
byP. pastoris using this signal sequence, and also reported for other
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recombinant plant lectins (Raemaekers et al., 1999; Lannoo et al.,
2007).
As expected, PprFTL was N-glycosylated by P. pastoris, since
the corresponding protein sequence has one potential site for N-
glycosylation (α-Asn74). Part of the secreted PprFTL undergone
this post-translational modiﬁcation, which led to an extension
in its molecular weight of about 2.8 kDa (Oliveira et al., 2011).
PprFTL, contrarily to FTL, did not agglutinate rabbit erythrocytes,
despite also having a tetrameric structure (Oliveira et al., 2008).
Thus, it was hypothesized that glycosylation pattern of P. pastoris
inhibited this activity since non-glycosylated EcrFTL presented
HA. In a previous work, Pichia glycosylation was also suggested to
inhibit the HA of a fungal lectin (Iijima et al., 2003). Nevertheless,
it should be noted that different FTL coding sequences were cloned
in P. pastoris and E. coli, and hence the HA of the resulting proteins
may differ. The deduced amino-acid sequences of the frutalin cod-
ifying genes cloned in P. pastoris and E. coli have 93% of sequence
identity (Figure 1). In what concerns carbohydrate-binding activ-
ity, PprFTL presented a sugar preference similar to FTL, but with
less afﬁnity. The afﬁnity constant for the binding of PprFTL to the
monosaccharidemethyl-α-galactose was determined and found to
be 113-fold lower than that of FTL (Oliveira et al., 2008). The only
other gJRL so far produced in microorganisms was jacalin. Jacalin
was produced in E. coli also as an unprocessed protein with its
sugar-binding activities reduced in the same order of magnitude
(Sahasrabuddhe et al., 2004). The correct excision of the linker
and consequent generation of a free glycine at the N-terminus
of the α chain may determine gJRLs sugar-binding properties
(Houles Astoul et al., 2002; Sahasrabuddhe et al., 2004; Oliveira
et al., 2008).
The large-scale production of PprFTL was conducted in a
1.6 L stirred tank bioreactor operating in fed-batch mode at
28◦C during 4 days (Wanderley et al., 2013). Supplementation
of the culture medium (BMMH – buffered minimal methanol
medium) with Pichia trace minerals (PTM) resulted in 2.5-fold
higher PprFTL production (13.4 mg/l) than that achieved without
supplementation (5.23 mg/l). Furthermore, bioreactor resulted in
fourfold higher PprFTL production, comparing to shaker-ﬂasks
batch assays (3.3 mg/l), using the same culture medium (BMMH
plus PTM) and induction conditions (Wanderley et al., 2013).
Nevertheless, the yield of PprFTL was higher from shake-ﬂasks
induced at 15◦C (18–20 mg/l), which means that lower temper-
atures favor PprFTL production (Oliveira et al., 2008). However,
20 of such ﬂasks (each containing 50 ml of BMMH medium) are
needed to obtain the same amount of PprFTL as in one fed-batch
experiment. Thus, bioreactor fermentation is more advantageous
for the production of PprFTL.
BIOMEDICAL PROPERTIES
The relevance of JRLs, speciﬁcally jacalin, for cancer diagnostics
and therapeutics is present inmany recent works (e.g., Obaid et al.,
2012; Lee et al., 2013;Marangoni et al., 2013; Zupancic et al., 2014).
PprFTL was evaluated in terms of its tumor biomarker and anti-
tumor properties, comparatively to FTL (Oliveira et al., 2009b,
2011). The cancer biomarker study was performed by immuno-
histochemistrywithhumanprostate tissues (Oliveira et al., 2009b).
Other plant lectins were used in the past in similar studies but with
limited success (works cited in Oliveira et al., 2009b). The binding
pattern of PprFTL and FTL to the prostate tissues was distinct, pre-
sumably due to their differences in carbohydrate-binding afﬁnity
(Oliveira et al., 2008). FTL bound to any type of prostate cells but
more strongly to the neoplasic (malignant cells) than to the hyper-
plasic ones (non-malignant cells). On the other hand, PprFTL
was much more speciﬁc, as it just recognized malignant cells
(Figure 2). A signiﬁcant positive statistical correlation between
the binding intensity of PprFTL and the histological diagnosis of
the tissues was obtained (not observed for FTL), although PprFTL
did not recognize all the malignant cases studied (30% had nega-
tive binding), and when positive, the binding was heterogeneous.
However, only a small number of prostate cases were analyzed and
the histochemical methodology has still room for improvement.
This study indicates that PprFTL has higher potential as cancer
biomarker than FTL.
In in vitro assays, PprFTL showed a strong cytotoxic effect on
HeLa cervical cancer cells proliferation, by inducing cell dead by
apoptosis (Oliveira et al., 2011). This effect was irreversible as well
as time and dose dependent (IC50 ∼ 100 μg/mL). Identical results
were obtained for FTL in the same study (Oliveira et al., 2011).
FIGURE 2 | Immunostaining pictures of a prostate cancer tissue using
recombinant FTL produced in P. pastoris as tumor diagnostic marker.
PprFTL was able to speciﬁcally recognize carcinoma cells in middle of a
benign lesion. The staining is localized in the cells cytoplasm of the carcinoma
glands (brown color). (Original publisher: BioMed Central; Adapted from
Oliveira et al., 2009b).
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Thus, it seems that frutalin action in tumor cells is not exclu-
sively dependent on its carbohydrate-binding properties. Other
factors, such as protein–protein interactions, may contribute to
the cellular responses, as suggested for the effect of recombinant
jacalin in tumor cells (Sahasrabuddhe et al., 2006). Recombinant
jacalin showed a magnitude of anti-proliferative responses similar
to native jacalin on human cancer cell lines, despite its inferior
sugar-binding afﬁnity (Sahasrabuddhe et al., 2006). Both, PprFTL
and FTL showed nuclearmigration activity onHeLa cells (Oliveira
et al., 2011), a property only reported for fungal lectins (Yu et al.,
1999; Francis et al., 2003; Liang et al., 2009). Plant lectins have
been described to attach to cancer cells membrane [e.g., jacalin in
A431 human epidermoid carcinoma cells (Sahasrabuddhe et al.,
2006)] or to be internalized and located in different cellular com-
partments [e.g., wheat germ agglutinin, WGA, in DU-145 human
prostate cancer cells (Gabor et al., 2001)]. To our knowledge, our
work is the ﬁrst reporting nuclear migration activity on cancer
cells for a lectin from plant origin (Oliveira et al., 2011). Studies
aiming to elucidate the apoptotic mechanism triggered by PprFTL
on cancer cells are now being conducted.
CONCLUSION AND PROSPECTS
Escherichia coli and Pichia pastoris were found as suitable hosts
for producing high amounts of recombinant FTL upon pro-
duction and puriﬁcation optimization. Optimization in E. coli
signiﬁcantly improved EcrFTL production, leading to high yields,
but decreased protein stability. Furthermore, the processing of
recombinant FTL in both microorganisms was different from that
occurring in breadfruit, resulting in versions of FTL with infe-
riorHA and carbohydrate-binding capacity. Nevertheless, PprFTL
presented an anti-tumor activity identical to FTL and enhanced
tumor biomarker capacity. The production strategies herein pre-
sented will extend the research on the biomedical properties of
recombinant FTL.
The importance of amino-acids substitutions and post-
translational modiﬁcations in gJRLs (e.g., linker cleavage, gly-
cosylation) remains to be elucidated, and thus, future research
might follow this direction. Within this scope, production and
the availability of heterologous recombinant lectins is a valuable
tool that can contribute to the fundamental understanding of
the biological activity of the lectins. The production of the same
lectin coding sequence in prokaryotic and eukaryotic hosts, the
production of different lectin isoforms, and engineered/mutated
versions, will provide insight into lectins functionality and shed
light into its native physiological role. Furthermore, recombi-
nant lectins with reﬁned properties can be obtained. Finally, the
fusion of enhanced lectins with functional moieties, by using
recombinant DNA technology, for the development of function-
alized drug delivery systems for site speciﬁc anti-tumor therapy, is
anticipated.
AUTHOR CONTRIBUTIONS
CarlaOliveira drafted the review and carried outmost of the exper-
imental work of recombinant FTL. José A. Teixeira participated in
the development of the concept. Lucília Domingues conceived the
study andhelped to draft the review. All authors read and approved
the ﬁnal manuscript.
ACKNOWLEDGMENTS
Carla Oliveira acknowledges support from Fundação para
a Ciência e a Tecnologia (FCT), Portugal (by the fellow-
ship SFRH/BDP/63831/2009). The authors thank the FCT
GlycoCBMs Project REF. FCT PTDC/AGR-FOR/3090/2012 –
FCOMP-01-0124-FEDER-027948, the FCT Strategic Project PEst-
OE/EQB/LA0023/2013, and the Project “BioInd – Biotechnology
and Bioengineering for improved Industrial and Agro-Food pro-
cesses,” REF. NORTE-07-0124-FEDER-000028 Co-funded by the
ProgramaOperacional Regional doNorte (ON.2 –ONovoNorte),
QREN, FEDER.
REFERENCES
Al Atalah, B., Fouquaert, E., Vanderschaeghe, D., Proost, P., Balzarini, J.,
Smith, D. F., et al. (2011). Expression analysis of the nucleocytoplasmic
lectin ‘Orysata’ from rice in Pichia pastoris. FEBS J. 278, 2064–2079. doi:
10.1111/j.1742-4658.2011.08122.x
Berlec, A., and Strukelj, B. (2013). Current state and recent advances in biophar-
maceutical production in Escherichia coli, yeasts and mammalian cells. J. Ind.
Microbiol. Biotechnol. 40, 257–274. doi: 10.1007/s10295-013-1235-0
Brando-Lima,A. C., Saldanha-Gama, R. F.,Henriques,M.,Monteiro-Moreira,A. C.,
Moreira, R. A., and Barja-Fidalgo, C. (2005). Frutalin, a galactose-binding lectin,
induces chemotaxis and rearrangement of actin cytoskeleton in human neu-
trophils: involvement of tyrosine kinase and phosphoinositide 3-kinase. Toxicol.
Appl. Pharmacol. 208, 145–154. doi: 10.1016/j.taap.2005.02.012
Brando-Lima, A. C., Saldanha-Gama, R. F., Pereira, C. R., Villela, C. G.,
Sampaio, A. L., Monteiro-Moreira, A. C., et al. (2006). Involvement of
phosphatidylinositol-3 kinase-Akt and nuclear factor kappa-B pathways in the
effect of frutalin on human lymphocyte. Int. Immunopharmacol. 6, 465–472. doi:
10.1016/j.intimp.2005.09.008
Campana, P.T.,Moraes,D. I.,Monteiro-Moreira,A.C., andBeltramini, L.M. (2002).
Unfolding and refolding studies of frutalin, a tetrameric D-galactose binding
lectin. Eur. J. Biochem. 269, 753–758. doi: 10.1046/j.0014-2956.2002.02742.x
Costa, S. (2013). Development of A Novel Fusion System for Recombinant Protein
Production and Puriﬁcation In Escherichia coli. Ph.D. thesis, University of Minho,
Braga.
Costa, S., Almeida, A., Castro, A., and Domingues, L. (2014). Fusion tags for protein
solubility, puriﬁcation and immunogenicity in Escherichia coli: the novel Fh8
system. Front. Microbiol. 5:63. doi: 10.3389/fmicb.2014.00063
Costa, S. J., Almeida, A., Castro, A., Domingues, L., and Besir, H. (2013a). The
novel Fh8 and H fusion partners for soluble protein expression in Escherichia
coli: a comparison with the traditional gene fusion technology. Appl. Microbiol.
Biotechnol. 97, 6779–6791. doi: 10.1007/s00253-012-4559-1
Costa, S. J., Coelho, E., Franco, L., Almeida, A., Castro, A., and Domingues,
L. (2013b). The Fh8 tag: a fusion partner for simple and cost-effective pro-
tein puriﬁcation in Escherichia coli. Protein Expr. Purif. 92, 163–170. doi:
10.1016/j.pep.2013.09.013
de Vasconcellos Abdon, A. P., Coelho De Souza, G., Noronha Coelho De
Souza, L., Prado Vasconcelos, R., Araujo Castro, C., Moreira Guedes, M.,
et al. (2012). Gastroprotective potential of frutalin, a D-galactose binding
lectin, against ethanol-induced gastric lesions. Fitoterapia 83, 604–608. doi:
10.1016/j.ﬁtote.2012.01.005
Fouquaert, E., Smith, D. F., Peumans, W. J., Proost, P., Balzarini, J., Savvides,
S. N., et al. (2009). Related lectins from snowdrop and maize differ in their
carbohydrate-binding speciﬁcity. Biochem. Biophys. Res. Commun. 380, 260–265.
doi: 10.1016/j.bbrc.2009.01.048
Francis, F., Marty-Detraves, C., Poincloux, R., Baricault, L., Fournier, D., and
Paquereau, L. (2003). Fungal lectin, XCL, is internalized via clathrin-dependent
endocytosis and facilitates uptake of othermolecules. Eur. J. Cell Biol. 82, 515–522.
doi: 10.1078/0171-9335-8
Fu, L. L., Zhou, C. C., Yao, S., Yu, J. Y., Liu, B., and Bao, J. K. (2011). Plant lectins:
targeting programmed cell death pathways as antitumor agents. Int. J. Biochem.
Cell Biol. 43, 1442–1449. doi: 10.1016/j.biocel.2011.07.004
Gabor, F., Klausegger, U., and Wirth, M. (2001). The interaction between wheat
germ agglutinin and other plant lectins with prostate cancer cells Du-145. Int. J.
Pharm. 221, 35–47. doi: 10.1016/S0378-5173(01)00650-0
www.frontiersin.org August 2014 | Volume 5 | Article 390 | 5
Oliveira et al. Recombinant frutalin – production and application
Gasser, B., Prielhofer, R., Marx, H., Maurer, M., Nocon, J., Steiger, M., et al. (2013).
Pichia pastoris: protein production host and model organism for biomedical
research. Future Microbiol. 8, 191–208. doi: 10.2217/fmb.12.133
Houles Astoul, C., Peumans, W. J., Van Damme, E. J., Barre, A., Bourne, Y., and
Rouge, P. (2002). The size, shape and speciﬁcity of the sugar-binding site of the
jacalin-related lectins is profoundly affected by the proteolytic cleavage of the
subunits. Biochem. J. 367(Pt 3), 817–824. doi: 10.1042/BJ20020856
Iijima, N., Amano, K., Ando, A., and Nagata, Y. (2003). Production of fruiting-body
lectins of Pleurotus cornucopiae in methylotrophic yeast Pichia pastoris. J. Biosci.
Bioeng. 95, 416–418. doi: 10.1016/S1389-1723(03)80079-8
Lannoo, N., Vervecken, W., Proost, P., Rouge, P., and Van Damme, E. J. M. (2007).
Expression of the nucleocytoplasmic tobacco lectin in the yeast Pichia pastoris.
Protein Expr. Purif. 53, 275–282. doi: 10.1016/j.pep.2007.01.007
Lee, C. S.,Muthusamy,A., Abdul-Rahman, P. S., Bhavanandan,V. P., and Hashim,O.
H. (2013). An improved lectin-based method for the detection of mucin-type O-
glycans in biological samples. Analyst 138, 3522–3529. doi: 10.1039/c3an36258b
Li, C. Y., Luo, P., Liu, J. J., Wang, E. Q., Li, W. W., Ding, Z. H., et al.
(2011). Recombinant expression of Polygonatum cyrtonema lectin with anti-viral,
apoptosis-inducing activities and preliminary crystallization. Process Biochem. 46,
533–542. doi: 10.1016/j.procbio.2010.10.005
Liang, Y., Feng, L., Tong, X., Wang, K., Li, D. F., Lin, J. C., et al. (2009). Importance
of nuclear localization for the apoptosis-induced activity of a fungal galectin AAL
(Agrocybe aegerita lectin). Biochem. Biophys. Res. Commun. 386, 437–442. doi:
10.1016/j.bbrc.2009.06.054
Liu, B., Bian, H. J., and Bao, J. K. (2010). Plant lectins: potential antineoplastic drugs
from bench to clinic. Cancer Lett. 287, 1–12. doi: 10.1016/j.canlet.2009.05.013
Marangoni, V. S., Paino, I. M., and Zucolotto, V. (2013). Synthesis and charac-
terization of jacalin-gold nanoparticles conjugates as speciﬁc markers for cancer
cells. Colloids Surf. B Biointerfaces 112, 380–386. doi: 10.1016/j.colsurfb.2013.
07.070
Mislovicova, D., Gemeiner, P., Kozarova, A., and Kozar, T. (2009). Lectinomics I.
Relevance of exogenous plant lectins in biomedical diagnostics. Biologia 64, 1–19.
doi: 10.2478/s11756-009-0029-3
Moreira, R. A., Castelo-Branco, C. C., Monteiro, A. C., Tavares, R. O., and
Beltramini, L. M. (1998). Isolation and partial characterization of a lectin from
Artocarpus incisa L. seeds. Phytochemistry 47, 1183–1188. doi: 10.1016/S0031-
9422(97)00753-X
Nobre, T. M., Pavinatto, F. J., Cominetti, M. R., Selistre De-Araujo, H. S.,
Zaniquelli, M. E., and Beltramini, L. M. (2010). The speciﬁcity of frutalin
lectin using biomembrane models. Biochim. Biophys. Acta 1798, 1547–1555. doi:
10.1016/j.bbamem.2010.03.021
Obaid, G., Chambrier, I., Cook, M. J., and Russell, D. A. (2012). Targeting the
oncofetal Thomsen-Friedenreich disaccharide using jacalin-PEG phthalocyanine
gold nanoparticles for photodynamic cancer therapy. Angew. Chem. Int. Ed. Engl.
51, 6158–6162. doi: 10.1002/anie.201201468
Ohba, H., Bakalova, R., and Muraki, M. (2003). Cytoagglutination and cyto-
toxicity of Wheat Germ Agglutinin isolectins against normal lymphocytes and
cultured leukemic cell lines – relationship between structure and biological
activity. Biochim. Biophys. Acta 1619, 144–150. doi: 10.1016/S0304-4165(02)
00479-8
Oliveira, C., Costa, S., Teixeira, J. A., and Domingues, L. (2009a). cDNA
cloning and functional expression of the α-D-galactose-binding lectin frutalin
in Escherichia coli. Mol. Biotechnol. 43, 212–220. doi: 10.1007/s12033-009-
9191-7
Oliveira, C., Felix, W., Moreira, R. A., Teixeira, J. A., and Domingues, L. (2008).
Expression of frutalin, an α-D-galactose-binding jacalin-related lectin, in the
yeast Pichia pastoris. Protein Expr. Purif. 60, 188–193. doi: 10.1016/j.pep.2008.
04.008
Oliveira, C., Nicolau, A., Teixeira, J. A., and Domingues, L. (2011). Cyto-
toxic effects of native and recombinant frutalin, a plant galactose-binding
lectin, on HeLa cervical cancer cells. J. Biomed. Biotechnol. 2011, 568932. doi:
10.1155/2011/568932
Oliveira, C., Teixeira, J. A., and Domingues, L. (2013). Recombinant lectins: an
array of tailor-made glycan-interaction biosynthetic tools. Crit. Rev. Biotechnol.
33, 66–80. doi: 10.3109/07388551.2012.670614
Oliveira, C., Teixeira, J. A., Schmitt, F., and Domingues, L. (2009b). A comparative
study of recombinant and native frutalin binding to human prostate tissues. BMC
Biotechnol. 9:78. doi: 10.1186/1472-6750-9-78
Pineau, N., Pousset, J. L., Preud’homme, J. L., and Aucouturier, P. (1990). Structural
and functional similarities of breadfruit seed lectin and jacalin. Mol. Immunol.
27, 237–240. doi: 10.1016/0161-5890(90)90135-M
Raemaekers, R. J. M., De Muro, L., Gatehouse, J. A., and Fordham-Skelton, A. P.
(1999). Functional phytohemagglutinin (PHA) and Galanthus nivalis agglutinin
(GNA) expressed in Pichia pastoris – Correct N-terminal processing and secre-
tion of heterologous proteins expressed using the PHA-E signal peptide. Eur. J.
Biochem. 265, 394–403. doi: 10.1046/j.1432-1327.1999.00749.x
Sahasrabuddhe, A. A., Ahmed, N., and Krishnasastry, M. V. (2006). Stress-induced
phosphorylationof caveolin-1 andp38, anddown-regulationof EGFr andERKby
the dietary lectin jacalin in two human carcinoma cell lines. Cell Stress Chaperones
11, 135–147. doi: 10.1379/CSC-160R.1
Sahasrabuddhe, A. A., Gaikwad, S. M., Krishnasastry, M. V., and Khan, M. I. (2004).
Studies on recombinant single chain jacalin lectin reveal reduced afﬁnity for
saccharides despite normal folding like native jacalin. Protein Sci. 13, 3264–3273.
doi: 10.1110/ps.04968804
Wanderley, M. S. O., Oliveira, C., Bruneska, D., Domingues, L., Lima, J. L., Teixeira,
J. A., et al. (2013). Inﬂuence of trace elements supplementation on the production
of recombinant frutalin by Pichia pastoris KM71H in fed-batch process. Chem.
Pap. 67, 682–687. doi: 10.2478/s11696-013-0363-3
Yu, L. G., Fernig, D. G., White, M. R. H., Spiller, D. G., Appleton, P.,
Evans, R. C., et al. (1999). Edible mushroom (Agaricus bisporus) lectin,
which reversibly inhibits epithelial cell proliferation, blocks nuclear localization
sequence-dependent nuclear protein import. J. Biol. Chem. 274, 4890–4899. doi:
10.1074/jbc.274.8.4890
Zupancic, D., Kreft, M. E., and Romih, R. (2014). Selective binding of lectins
to normal and neoplastic urothelium in rat and mouse bladder carcinogenesis
models. Protoplasma 251, 49–59. doi: 10.1007/s00709-013-0524-9
Zwierzina, H., Bergmann, L., Fiebig, H., Aamdal, S., Schoffski, P.,Witthohn, K., et al.
(2011). The preclinical and clinical activity of aviscumine: a potential anticancer
drug. Eur. J. Cancer 47, 1450–1457. doi: 10.1016/j.ejca.2011.02.022
Conflict of Interest Statement: The authors declare that the researchwas conducted
in the absence of any commercial or ﬁnancial relationships that could be construed
as a potential conﬂict of interest.
Received: 31 May 2014; accepted: 22 July 2014; published online: 08 August 2014.
Citation: Oliveira C, Teixeira JA and Domingues L (2014) Recombinant production of
plant lectins in microbial systems for biomedical application – the frutalin case study.
Front. Plant Sci. 5:390. doi: 10.3389/fpls.2014.00390
This article was submitted to Plant Physiology, a section of the journal Frontiers in
Plant Science.
Copyright © 2014 Oliveira, Teixeira and Domingues. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal is cited,
in accordance with accepted academic practice. No use, distribution or reproduction is
permitted which does not comply with these terms.
Frontiers in Plant Science | Plant Physiology August 2014 | Volume 5 | Article 390 | 6
